The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
4 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $9,005,538 in first-year total cost, median $2,419,519.
Most frequent study sections
- Special Emphasis Panel[ZNS1 SRB-G (04)]2
- Neurological Sciences and Disorders K Study Section[NSD-K]1
- Special Emphasis Panel[ZNS1 SRB-G (73)]1
Most frequent institutions
- CEDARS-SINAI MEDICAL CENTER1
- RUSH UNIVERSITY MEDICAL CENTER1
- UNIVERSITY OF ALABAMA AT BIRMINGHAM1
- UNIVERSITY OF UTAH1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2017 | Topiramate as a Disease Altering Therapy for CSPN1U01NS095388-01A1 | COFFEY, CHRISTOPHER S.CUDKOWICZ, MERIT ESINGLETON, JOHN ROBINSONSMITH, A. GORDONVINIK, AARON I. | UNIVERSITY OF UTAH, UT | $2,399,189 | NSD |
| 2016 | Effects of AFQ056 on Language Learning in Young Children with Fragile X Syndrome (FXS)1U01NS096767-01 | ABBEDUTO, LEONARD J.BERRY-KRAVIS, ELIZABETH MARAHAGERMAN, RANDI J. | RUSH UNIVERSITY MEDICAL CENTER, IL | $3,473,471 | ZNS1 |
| 2016 | Cytochrome C Oxidase: Biomarker In Newly Diagnosed Glioblastoma Multiforme1U01NS093663-01A1 | GRIGUER, CORINNE E.MARKERT, JAMES M | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | $693,029 | ZNS1 |
| 2014 | ZZ-3K3A-201: Safety evaluation of 3K3A-APC in ischemic stroke1U01NS088312-01 | LYDEN, PATRICK D | CEDARS-SINAI MEDICAL CENTER, CA | $2,439,849 | ZNS1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.